Retinoic acid receptor antagonists for male contraception: current status(†)

Retinoic acid receptor alpha (RARA), a nuclear receptor protein, has been validated as a target for male contraception by gene knockout studies and also pharmacologically using a pan-retinoic acid receptor antagonist. Retinoic acid receptor alpha activity is indispensable for the spermatogenic proce...

Descripción completa

Detalles Bibliográficos
Autores principales: Noman, Md Abdullah Al, Kyzer, Jillian L, Chung, Sanny S W, Wolgemuth, Debra J, Georg, Gunda I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Contraceptive Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401398/
https://www.ncbi.nlm.nih.gov/pubmed/32671394
http://dx.doi.org/10.1093/biolre/ioaa122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401398/
https://www.ncbi.nlm.nih.gov/pubmed/32671394
http://dx.doi.org/10.1093/biolre/ioaa122

Ejemplares similares